🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a prospective, multicenter, randomized, open label study to investi...
Status
Unknown
Location
Guangdong Provincial People's Hospital
Start Date
2021-08
Trial ID
NCT04988607
Treatments Being Tested
This is a Phase 1/1b open-label study evaluating the safety, pharmacokineti...
Status
Active Not Recruiting
Location
Scottsdale Healthcare /ID# 123761
Start Date
2014-01-15
Trial ID
NCT02099058
Treatments Being Tested
A Phase 1/2 multi-center open-label study of BGB324 (bemcentinib) as a sing...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-04-19
Trial ID
NCT02424617
Treatments Being Tested
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03944772
The goal of this observational study is to extract the imaging features of ...
Status
Recruiting
Location
Shanghai Cancer center
Start Date
2024-09-30
Trial ID
NCT06604689
Treatments Being Tested
This is a Phase 1/2, open-label, first-in-human (FIH) study is designed to ...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2022-01-13
Trial ID
NCT05153408
Treatments Being Tested
The goal of this observational study is to explore the feasibility of stere...
Status
Completed
Location
Wuhan Tongji Hospital
Start Date
2018-09-01
Trial ID
NCT06613633
Treatments Being Tested
This is an open-label, dose escalation and expansion study to evaluate the ...
Status
Recruiting
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2021-03-24
Trial ID
NCT04665206
Treatments Being Tested